本页面由Tiger Trade Technology Pte. Ltd.提供服务

美国血液技术

122.06
+3.372.84%
盘后:122.060.00000.00%19:30 EDT
成交量:89.51万
成交额:1.08亿
市值:55.47亿
市盈率:59.54
高:122.24
开:118.70
低:118.36
收:118.69
52周最高:122.24
52周最低:48.17
股本:4,544.60万
流通股本:4,459.72万
量比:0.77
换手率:2.01%
股息:- -
股息率:- -
每股收益(TTM):2.05
每股收益(LYR):2.05
净资产收益率:11.20%
总资产收益率:6.60%
市净率:6.63
市盈率(LYR):59.54

数据加载中...

2023/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/07

重要事件披露

Form 8-K - Current report
2023/07/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/05/11

重要事件披露

8-K - Current report
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/07

重要事件披露

8-K - Current report
2023/02/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/07

重要事件披露

8-K - Current report